1. Home
  2. DLPN vs MRKR Comparison

DLPN vs MRKR Comparison

Compare DLPN & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.72

Market Cap

20.6M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.61

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
MRKR
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.6M
24.5M
IPO Year
2008
2010

Fundamental Metrics

Financial Performance
Metric
DLPN
MRKR
Price
$1.72
$1.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$10.17
AVG Volume (30 Days)
41.2K
212.2K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
27.81
N/A
EPS
N/A
N/A
Revenue
$51,684,984.00
N/A
Revenue This Year
$10.62
N/A
Revenue Next Year
$13.78
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.85
N/A
52 Week Low
$0.75
$0.81
52 Week High
$1.88
$4.07

Technical Indicators

Market Signals
Indicator
DLPN
MRKR
Relative Strength Index (RSI) 61.33 52.65
Support Level $1.46 $1.37
Resistance Level $1.73 $1.88
Average True Range (ATR) 0.09 0.12
MACD 0.02 0.00
Stochastic Oscillator 94.64 62.07

Price Performance

Historical Comparison
DLPN
MRKR

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: